Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal

From the source

Reed Jobs isn’t trying to cure cancer. For Jobs—an investor and, yes, Steve Jobs’s son—the aim’s far more precise: To make cancer non-lethal. The rhetorical distinction is important. “I don’t think you’ll cure cancer because we’re human,” said Jobs. “Any human cell could become cancerous, right? And we’re not going to stop having human cells. So, the idea that none of them could ever become cancer is preposterous. That risk’s never going away.” And medicine, however advanced it may be, seldom makes diseases vanish. But there’s a path to a world where cancer is much less intractable. Consider, Jobs says, the trajectory of AIDS as a guide to what might be possible for cancer treatment. “There’s no vaccine for [AIDS], unfortunately,” he said. “I’d love for there to be, but in the absence of that, it’s a far less scary disease now in the United States because it’s non-lethal. With a cocktail of drugs, you can actually prevent mortality. In many ways, I think that’s a massive victory and,…

BestAIBroker analysis

• Finance-aware sentiment: slightly positive (+0.20 on a -1 to +1 scale).
• Event classification: OTHER.
• Market importance score: 31/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.